Latest stories on SRPT
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SRPT Stock News
StockTitan50 · neutralgeneral
Leadership changes afoot at two CGT biotechs
Yahoo Top42 · neutralgeneral
H.C. Wainwright reiterates Sarepta stock Sell rating on CEO transition
Investing.com Analyst Ratings34 · bearishanalyst
Morgan Stanley Views Sarepta CEO Transition As A ‘Positive’ – So, Why Is It Cautious On SRPT Stock In The Near Term?
Stocktwits News54 · neutralanalyst
Sarepta Therapeutics Appoints Michael Severino as CEO
TipRanks55 · neutralgeneral
Why is Sarepta Therapeutics stock climbing today?
Investing.com Markets50 · neutralgeneral
Sarepta Therapeutics, Inc. (SRPT) files 8-K
SEC 8-K50 · neutralgeneral
Sarepta Therapeutics Names Michael Severino, M.D., as New CEO—Leadership Transition Brings Deep Industry Expertise
July 27, 2026
MarketChameleon63 · neutralproduct/pr
Sarepta taps Michael Severino as CEO
Seeking Alpha67 · bullishgeneral
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer | SRPT Stock News
StockTitan56 · neutralgeneral
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
Yahoo Top54 · neutralgeneral
Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results | SRPT Stock News
StockTitan50 · neutralearnings
SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space
Stocktwits News34 · bearishanalyst
This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next
Stocktwits News67 · bullishanalyst
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SRPT Stock News
StockTitan50 · neutralgeneral
SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies
Stocktwits News67 · bullishproduct/pr
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53® | SRPT Stock News
StockTitan67 · bullishproduct/pr
Sarepta: Caution Still Warranted Despite FDA's Gene Therapy-Friendly Stance
Seeking Alpha42 · neutralgeneral
Sarepta Therapeutics, Inc. (SRPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors | PRVCF Stock News
StockTitan57 · neutralgeneral
Sarepta Therapeutics, Inc. (SRPT) Shareholder/Analyst Call Transcript
Seeking Alpha50 · neutralgeneral
Sarepta Therapeutics to Participate in Upcoming Investor Conferences | SRPT Stock News
StockTitan56 · neutralgeneral
In Solid Cash Position, Sarepta Therapeutics Inc (SRPT) Outlines 2026 Priorities
Yahoo Finance72 · bullishgeneral
Why Elevidys Matters For Sarepta Therapeutics Inc (SRPT) Stock
Yahoo Finance73 · bullishearnings